Gina Mazzariello - 22 May 2025 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Chief Legal Officer
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
27 May 2025, 16:01:25 UTC
Previous filing
02 Apr 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mazzariello Gina Chief Legal Officer C/O AMYLYX PHARMACEUTICALS, INC., 43 THORNDIKE STREET, CAMBRIDGE /s/ Joshua B. Cohen, as Attorney in Fact 27 May 2025 0001913765

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Gift $0 -1,000 -0.53% $0.000000 186,969 22 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift for no consideration.